NCT02639936Completed
New Generation IGRA in Immunocompromised Individuals
Performance of a New Generation IGRA in Immunocompromised Individuals
Source: ClinicalTrials.gov · Last updated 10 Apr 2025
Brief summary (registry, in English)
Evaluation of a new ELISA based interferon-gamma release assay (QuantiFERON TB plus In-tube test) in immunocompromized patients
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2663 (actual)
- First submitted
- 15 Dec 2015
- Start date
- Dec 2015
- Primary completion date
- Dec 2023
- Lead sponsor
- Tuberculosis Network European Trialsgroup
- NCT number
- NCT02639936
What you commit to
- Study type: Observational
- Participants enrolled: 2663
- From Dec 2015 to the primary completion date, Dec 2023
- 16 sites in 10 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- \<18 years of age
Who the study is looking for
- Individuals as specified for the study Population
- Written informed consent
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (16)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Research center Borstel Coordinator of this site? Confirm its status | Borstel | Germany | Unknown status |
| Freiburg University Coordinator of this site? Confirm its status | Freiburg im Breisgau | Germany | Unknown status |
| Saarland University Coordinator of this site? Confirm its status | Homburg | Germany | Unknown status |
| Rigshospitalet Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
| Institut d'Investigació Germans Trias i Pujol Coordinator of this site? Confirm its status | Badalona | Spain | Unknown status |
| Hospital Universitari Vall d'Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
| Hospital Universitario Central De Asturias Coordinator of this site? Confirm its status | Oviedo | Spain | Unknown status |
| Department of Respiratory Medicine, Royal Free Hospital Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| University of Brescia and Brescia Spedali Civili General Hospital Coordinator of this site? Confirm its status | Brescia | Italy | Unknown status |
| San Raffaele Scientific Institute Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
| National Institute for Infectious Diseases L. Spallanzani Coordinator of this site? Confirm its status | Rome | Italy | Unknown status |
| Department of Pneumology & Allergology Coordinator of this site? Confirm its status | Chisinau | Moldova | Unknown status |
| Department of Infectious Diseases; Oslo University Coordinator of this site? Confirm its status | Oslo | Norway | Unknown status |
| Warszawski Uniwersytet Medyczny Coordinator of this site? Confirm its status | Warsaw | Poland | Unknown status |
| Centro de Diagnóstico Pneumológico Coordinator of this site? Confirm its status | Vila Nova de Gaia | Portugal | Unknown status |
| Marius Nasta Institute of Pneumology Coordinator of this site? Confirm its status | Bucharest | Romania | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.